MARTELLUCCI, IGNAZIO
 Distribuzione geografica
Continente #
NA - Nord America 942
EU - Europa 836
AS - Asia 138
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.923
Nazione #
US - Stati Uniti d'America 938
GB - Regno Unito 265
IE - Irlanda 169
CN - Cina 110
UA - Ucraina 83
IT - Italia 76
SE - Svezia 75
DE - Germania 48
FR - Francia 45
RU - Federazione Russa 27
FI - Finlandia 26
SG - Singapore 11
ES - Italia 8
BE - Belgio 5
CI - Costa d'Avorio 5
VN - Vietnam 5
CA - Canada 4
IN - India 4
CZ - Repubblica Ceca 2
HK - Hong Kong 2
IR - Iran 2
NL - Olanda 2
AT - Austria 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
LK - Sri Lanka 1
LV - Lettonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TR - Turchia 1
VE - Venezuela 1
Totale 1.923
Città #
Southend 247
Dublin 166
Fairfield 159
Ashburn 80
Chandler 76
Woodbridge 72
Jacksonville 66
Seattle 66
Houston 59
Wilmington 55
Cambridge 44
Ann Arbor 43
Siena 38
Beijing 34
Princeton 29
Nanjing 28
New York 25
Helsinki 15
Shanghai 13
Munich 12
San Mateo 11
San Diego 10
Boardman 9
Moscow 8
Málaga 8
Florence 7
Singapore 7
Dearborn 6
Abidjan 5
Brussels 5
Nanchang 5
Cagliari 4
Dallas 4
Dong Ket 4
Hebei 4
London 4
Los Angeles 4
Ningbo 4
Renton 4
Fremont 3
Kunming 3
Toronto 3
Amsterdam 2
Auburn Hills 2
Brno 2
Changsha 2
Düsseldorf 2
Hangzhou 2
Hong Kong 2
Jiaxing 2
Menlo Park 2
Milan 2
Norwalk 2
Pune 2
Saint Petersburg 2
San Francisco 2
Shenyang 2
Tianjin 2
Washington 2
Bangalore 1
Berlin 1
Bologna 1
Bratislava 1
Brescia 1
Burlington 1
Böblingen 1
Changchun 1
Chengdu 1
Chicago 1
Colombo 1
Corato 1
Duncan 1
Dushanbe 1
Falkenstein 1
Frankfurt am Main 1
Guangzhou 1
Hanoi 1
Hendon 1
Hounslow 1
Hyderabad 1
Islington 1
Kilburn 1
Lancaster 1
Lanzhou 1
Leawood 1
Lucca 1
Nuremberg 1
Or Yehuda 1
Paris 1
Phoenix 1
Piombino 1
Poggio Renatico 1
Prescot 1
Redwood City 1
Riga 1
Sesto Fiorentino 1
Tappahannock 1
Vienna 1
Winnipeg 1
Yellow Springs 1
Totale 1.524
Nome #
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients. 221
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 214
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 133
Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients with fractioned cisplatinum, oral etoposide and bevacizumab: phase IB/II study 132
Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin 129
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients 129
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 121
Cisplatin, etoposide, and bevacizumab regimen followed by oral etoposide and bevacizumab maintenance treatment in patients with extensive-stage small cell lung cancer: A single-institution experience 120
Effects of intravenous Zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from NSCLC 119
Bevacizumab and weekly Doxetacel in patients with metastatic castrate-resistant prostate cancer previously exposed to Docetaxel 115
A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients 111
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients 105
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer 81
Sjögren's syndrome and aromatase inhibitors treatment: is there a link? 77
First-line pharmacotherapies and survival among patients diagnosed with non-resectable NSCLC: a real-life setting study with gender prospective 76
Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients with fractionated cisplatimum, oral etoposide, and bevacizumab 44
Head and Neck Carcinoma and biomarker profiling: searching tumor identity card. 17
Porcelain gallbladder and its relationship to cancer 13
null 3
Totale 1.960
Categoria #
all - tutte 6.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020352 0 12 21 60 17 23 36 61 38 39 23 22
2020/2021368 17 41 17 25 42 54 7 51 32 30 32 20
2021/2022241 20 19 13 18 15 10 9 10 12 29 31 55
2022/2023292 20 20 46 36 26 59 5 25 29 9 12 5
2023/2024275 5 4 24 12 10 82 98 9 3 10 3 15
2024/202559 33 26 0 0 0 0 0 0 0 0 0 0
Totale 1.960